v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net loss $ (43,253,000) $ (80,611,345)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 5,586,275 5,959,822
Stock-based compensation 1,568,812 8,206,673
Change in inventory and prepaid purchases reserve 7,363,255 1,084,906
Non-cash lease expense 984,919 580,123
Gain on sale of assets (13,805,791) 0
Other income (4,795,250) 0
Non-cash change in fair value of convertible notes 7,781,029 505,788
Non-cash change in fair value of warrants 4,205,035 6,655,120
Non-cash payment of convertible notes (381,212) 11,778,192
Original issuance discount - non-cash fees on convertible notes 4,812,499 2,917,250
Other non-cash items 910,863 0
Effects of changes in operating assets and liabilities:    
Accounts receivable (1,937,021) 785,394
Inventory, net 7,325,678 1,238,803
Prepaid expenses and other current assets 867,995 641,345
Other assets (240,000) 0
Accounts payable and accrued liabilities (1,857,937) 2,570,035
Deferred revenue (498,331) 1,636,250
Warranty liability 347,720 (1,126,224)
Net cash used in operating activities (25,014,462) (40,115,793)
Cash flows from investing activities:    
Proceeds from sale of assets 19,469,855 0
Capital expenditures 0 (4,027,565)
Net cash provided by (used in) investing activities 19,469,855 (4,027,565)
Cash flows from financing activities:    
Proceeds from convertible notes 33,687,500 28,250,000
Proceeds from Motive Convertible Note 5,000,000 0
Payments on convertible notes 0 (20,000,000)
Proceeds from issuance of common stock 406,963 4,366,649
Payments on finance lease 0 (903,357)
Exercise of options and restricted share award activity 6,949 (171,043)
Net cash provided by financing activities 39,101,412 11,542,249
Change in cash and cash equivalents and restricted cash 33,556,805 (32,601,109)
Cash and cash equivalents and restricted cash, beginning of the period 4,644,938 35,845,915
Cash and cash equivalents and restricted cash, end of the period 38,201,743 3,244,806
2023 Warrants    
Adjustments to reconcile net loss to net cash used in operating activities:    
Change in fair value and gain on conversion of 2026 Notes and 2023 Warrants $ 0 $ (2,937,925)

Source

HTML PDF
ZIP